Appili Therapeutics Inc. APLIF
APLIF
Appili Therapeutics Inc. ZLDAF
Zelira Therapeutics Limited SRNE
Sorrento Therapeutics, Inc. AXIM
AXIM Biotechnologies, Inc. CPMV
Mosaic ImmunoEngineering Inc. BIOE
Bio Essence Corporation RASP
Actavia Life Sciences, Inc. BSPK
Bespoke Extracts, Inc. IBOGF
Universal Ibogaine Inc. PKTX
ProtoKinetix, Incorporated
Appili Therapeutics Inc. ZLDAF
Zelira Therapeutics Limited SRNE
Sorrento Therapeutics, Inc. AXIM
AXIM Biotechnologies, Inc. CPMV
Mosaic ImmunoEngineering Inc. BIOE
Bio Essence Corporation RASP
Actavia Life Sciences, Inc. BSPK
Bespoke Extracts, Inc. IBOGF
Universal Ibogaine Inc. PKTX
ProtoKinetix, Incorporated
Performance
| Periode | APLIF | ZLDAF | SRNE | AXIM | CPMV | BIOE | RASP | BSPK | IBOGF | PKTX |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -19.35 % | -28.32 % | 677.78 % | 82.93 % | -36.62 % | -65.53 % | 0.00 % | 204.65 % | -61.75 % | -59.23 % |
| YTD | -19.03 % | -43.89 % | 775.00 % | 294.74 % | -37.61 % | -66.98 % | 0.00 % | 105.48 % | -37.50 % | -46.79 % |
| 1Y | -28.57 % | -57.68 % | 62.79 % | 114.29 % | -52.31 % | -97.55 % | 0.00 % | 20.06 % | -7.89 % | -41.11 % |
| 3Y | -44.37 % | -74.72 % | -54.25 % | -88.62 % | -47.18 % | -85.80 % | 53.85 % | -49.11 % | -63.16 % | -82.33 % |
| 5Y | -98.15 % | -98.11 % | -92.13 % | -98.77 % | -81.27 % | -85.80 % | -94.29 % | 3 521 016.43 % | -90.75 % | -94.49 % |
| 10Y | -98.49 % | -96.93 % | -91.94 % | -98.81 % | -94.11 % | -85.80 % | -99.13 % | 2 600.00 % | -90.75 % | -87.67 % |
| From the beginning | -98.49 % | -96.93 % | -91.88 % | -99.93 % | -99.28 % | -85.80 % | -99.35 % | -64.00 % | -90.75 % | -98.74 % |